SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20213205
Source:
http://linkedlifedata.com/resource/pubmed/id/20213205
Search
Subject
(
83
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0033137
,
umls-concept:C0205255
,
umls-concept:C0262926
,
umls-concept:C1169989
,
umls-concept:C1274040
,
umls-concept:C1280500
,
umls-concept:C2004062
pubmed:issue
7
pubmed:dateCreated
2010-6-10
pubmed:abstractText
Behaviors associated with opioid dependence often involve criminal activity, which can lead to incarceration. The impact of a history of incarceration on outcomes in primary care office-based buprenorphine/naloxone is not known.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/K01 DA022398
,
http://linkedlifedata.com/resource/pubmed/grant/R01 DA009803
,
http://linkedlifedata.com/resource/pubmed/grant/R01 DA019511
,
http://linkedlifedata.com/resource/pubmed/grant/R01 DA020576-05
,
http://linkedlifedata.com/resource/pubmed/grant/R01 DA025991
,
http://linkedlifedata.com/resource/pubmed/grant/R01DA020576
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-11419233
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-11452838
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-11563793
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-1334156
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-15049734
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-15917502
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-16870915
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-17215533
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-17356993
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-17371127
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-17583269
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-17619934
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-17644275
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-18222051
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-18770082
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-18804923
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-18855822
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-18930603
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-19141766
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-19229694
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-19339140
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-19426474
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-2288322
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-6619823
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-7866170
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20213205-9212538
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8605834
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Buprenorphine
,
http://linkedlifedata.com/resource/pubmed/chemical/Naloxone
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1525-1497
pubmed:author
pubmed-author:FiellinDavid ADA
,
pubmed-author:MooreBrent ABA
,
pubmed-author:SullivanLynn ELE
,
pubmed-author:WangEmily AEA
pubmed:issnType
Electronic
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
670-4
pubmed:dateRevised
2011-8-1
pubmed:meshHeading
pubmed-meshheading:20213205-Adult
,
pubmed-meshheading:20213205-Buprenorphine
,
pubmed-meshheading:20213205-Criminals
,
pubmed-meshheading:20213205-Female
,
pubmed-meshheading:20213205-Humans
,
pubmed-meshheading:20213205-Male
,
pubmed-meshheading:20213205-Middle Aged
,
pubmed-meshheading:20213205-Naloxone
,
pubmed-meshheading:20213205-Office Visits
,
pubmed-meshheading:20213205-Opioid-Related Disorders
,
pubmed-meshheading:20213205-Primary Health Care
,
pubmed-meshheading:20213205-Socioeconomic Factors
,
pubmed-meshheading:20213205-Treatment Outcome
,
pubmed-meshheading:20213205-Young Adult
pubmed:year
2010
pubmed:articleTitle
Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone.
pubmed:affiliation
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA. emily.wang@yale.edu
pubmed:publicationType
Journal Article
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Research Support, N.I.H., Extramural